These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8220893

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF, Headley PM.
    Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
    [Abstract] [Full Text] [Related]

  • 3. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG, West DC, Headley PM.
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [Abstract] [Full Text] [Related]

  • 4. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG, West DC, Headley PM.
    NIDA Res Monogr; 1986 Oct; 75():461-4. PubMed ID: 2828992
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Stimulus intensity and the comparative efficacy of mu- and kappa-opioid agonists on nociceptive spinal reflexes in the rat.
    Thorn SA, Herrero JF, Headley PM.
    Brain Res; 1994 Nov 14; 663(2):352-6. PubMed ID: 7874523
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.
    Parsons CG, Headley PM.
    Br J Pharmacol; 1989 Oct 14; 98(2):523-32. PubMed ID: 2555011
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF, Bettaney J, Perkins MN, Ketchum SB, Dray A.
    Br J Pharmacol; 1990 Mar 14; 99(3):503-8. PubMed ID: 2158845
    [Abstract] [Full Text] [Related]

  • 11. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
    Horan PJ, de Costa BR, Rice K, Haaseth RC, Hruby VJ, Porreca F.
    J Pharmacol Exp Ther; 1993 Aug 14; 266(2):926-33. PubMed ID: 8394923
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH, Gulati A, Bhargava HN.
    Pharmacology; 1991 Aug 14; 43(3):156-62. PubMed ID: 1663623
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of thymidine incorporation by kappa-opioid ligands in rat spinal cord-dorsal root ganglion co-cultures.
    Barg J, Nah SY, Levy R, Saya D, Vogel Z.
    Brain Res; 1993 Nov 26; 629(1):109-14. PubMed ID: 8287265
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.